Executive Leadership Team
The Executive Leadership Team (ELT) is responsible for setting and influencing Genomics England’s strategic direction (with the Board); defining, delivering and evaluating Genomics England’s activities: providing leadership, both inside the organisation and externally as ambassadors and thought leaders.
Prior to his appointment at Genomics England, Chris was COO at QuantumBlack, a bespoke machine learning and AI technology company, and a Partner at McKinsey working on technology strategy topics.
He previously worked for the UK Foreign Office (where he led analytical work at the Counter Terrorism Policy Department), and at the BBC (transitioning to digital broadcasting and iPlayer). He has held board roles at the New Entrepreneurs Foundation, Entrepreneur First and Magic Breakfast.
Chris lives in London with his wife Tara and their three children, and loves nothing more than a winter’s day climbing a snowy mountain followed by a nice dinner with a glass of Italian red wine.
Professor Sir Mark Caulfield
Chief Scientific Officer
Sir Mark engages with NHS scientific teams and the general public to promote, explains and enthuses about the 100,000 Genomes Project, and oversees the Clinical Interpretation Partnership and Access Review Committee. He is also responsible as Head of Profession (Science and Clinical) for helping us attract and retain the best scientific and clinical talent to the Project and ensuring our clinician community can develop professionally and appropriately within the Project.
Our Ethics team is also part of the Chief Scientific Officer’s team, supporting Genomics England in its ethical governance of the Project, working in line with participants’ consent, the Project’s aims and advising on compliance with relevant medical, academic and data legislation, regulation including Research Ethics Committee (REC) approval, professional guidance and good ethical practice. This includes seeking input from patient groups and Project participants. The Ethics team leads on ethical policy issues, and provides the secretariat for the Ethics Advisory Committee and its standing subgroups on Equalities, Consent and Legacy (the future of mainstreamed NHS genomics beyond the Project).
In January 2019, Sir Mark was appointed interim Chief Executive at Genomics England until October, and in June received a knighthood in the 2019 Queen’s Birthday Honours in recognition of his services to the 100,000 Genomes Project.
General Counsel and Company Secretary
He is responsible for all legal activity within Genomics England including ensuring that the organisation complies with the law (Data Protection, Freedom of Information, Human Tissues Act) and the Company’s Articles and policies.
He is also responsible for signing off all procurement and contracting work.
Prior to his role at Genomics England, Nick was a partner in three Top 100 law firms: Pinsent Masons, DLA Piper and Bircham Dyson Bell.
Chief Communications & Engagement Officer
Anna’s team is responsible for all internal and external-facing communications, reputation management and engagement strategies at Genomics England. The team works closely with participants and other stakeholders, including the Department of Health and Social Care, the Office for Life Sciences, NHS England, commercial partners and academic communities.
Anna holds a degree from Cambridge University, and began her career in investment banking. She joined Genomics England in 2019, and prior to this she held roles including Global Communications Director at US health giant, Aetna, and Group Marketing and Communications Director at InHealth Group.
Augusto and his team have designed and implemented the clinical interpretation pipelines that return findings to patients, while ensuring that knowledge accumulated through this process is best used to improve patient care and enhance discovery.
Chief Commercial and Partnerships Officer
Chief Information Officer
Chief Digital Officer
Rakhi joined Genomics England as CDO in May 2020 to drive innovation in healthcare products and services that put the patient and society at the core. She was previously an Associate Partner at QuantumBlack and McKinsey where she led global foresight and human-centred AI projects. Prior to that Rakhi has held senior innovation positions at startups and large organisations spanning emerging tech, healthcare, aerospace and defence, hospitality, and automotive. She is a Chartered Psychologist and holds degrees in Psychology, Engineering and Design.
Chief Transformation Officer
Catherine has over sixteen years’ experience in government, working in the Department of Health and Social Care, the Office for Lifesciences, in Cabinet Office and with No10. Most recently Catherine was Head of NHS Finance at DHSC from 2016-2019, and led on Lab Capacity in the DHSC Covid19 Testing Programme in Spring 2020. She also has experience of Genomics England, having worked with the organisation in 2014 during the 100,000 Genomes Project. Catherine brings a wealth of expertise in government finance, policy, programme management, governance and stakeholder management.
As Chief Transformation Officer, Catherine leads the finance, estates, quality and performance chapters at GEL. She will be working closely with all of the ELT and our new Tribes to embed our transformation and deliver on our new strategy.
Catherine lives in Essex with her husband and three children, and spends her spare time going for long walks in Epping Forest and cooking for family and friends.
Dr Richard Scott